Lamin A biogenesis, processing and progeria

核纤层蛋白 A 的生物发生、加工和早衰

基本信息

  • 批准号:
    7912046
  • 负责人:
  • 金额:
    $ 32.51万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-09-30 至 2012-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This project focuses on the biogenesis of Lamin A, a critical structural component of the nuclear envelope. Surprisingly, recent studies have revealed that mutations in the gene encoding Lamin A result in a wide range of diseases called the "laminopathies" (encompassing cardiomyopathy, muscular dystrophy, lipodystrophy, and progeroid disorders), leading to a resurgence of interest in the biology of Lamin A. The Lamin A precursor, prelamin A, undergoes a series of post-translational processing events, including: 1) C- terminal CaaX modification (prenylation, proteolysis, and carboxyl methylation), followed by 2) an endoproteolytic cleavage event, mediated by the zinc metalloprotease ZmpSte24, that removes the CaaX- modified C-terminus to yield mature Lamin A. In previous years of this project, our laboratory discovered ZmpSte24 as a key enzyme in the biogenesis of yeast a-factor. From these findings this project has evolved to study the biogenesis of Lamin A in mammalian cells. The most severe laminopathy is the premature aging disorder Hutchinson-Gilford Progeria Syndrome (HGPS). Strikingly, there appears to be a direct link between defective Zmpste24-mediated endoproteolytic processing of prelamin A and progeroid diseases based on the findings that: 1) HGPS results from a mutation in which the ZmpSte24 cleavage site within Lamin A is deleted, and 2) the progeroid disorders mandibuloacral dysplasia (MAD) and restrictive dermopathy (RD) map to ZmpSte24. Thus, it appears that the persistently prenylated form of Lamin A that is present in HGPS or zmpste24-/- cells leads to accelerated aging pathologies. In this proposal we will define key cell biological aspects of Lamin A processing and address the role that a lack of processing plays in disease mechanisms. We will use molecular, cell biological, genetic, and biochemical approaches to address the following aims: Aim 1) determine the cellular location of Lamin A processing (nucleoplasmic vs. the cytosolic face of the ER); Aim 2) determine the fate of the cleaved C- terminal tail; Aim 3) determine the recognition sequences within prelamin A important for ZmpSte24 cleavage, and define how Zmpste24 cleaves prelamin A using purified enzyme; and Aim 4) investigate the molecular mechanisms by which failure to cleave the prelamin A tail leads to cellular and disease phenotypes. In particular we will test whether methylation may contribute to the toxicity of Lamin A in HGPS. The intriguing finding that progeroid diseases are caused by incomplete processing of prelamin A has underscored the importance of a comprehensive understanding of the entire processing pathway, which we address in this proposal. Our studies will provide insight into therapeutic options for progeroid disorders. The significance of this research is heightened by recent findings that inhibition of ZmpSte24-mediated processing of prelamin A may contribute to HIV therapy-induced side effects, and possibly to the mechanisms of normal aging. PUBLIC HEALTH RELEVANCE: Mutations in the nuclear structural protein Lamin A cause the premature aging disorder Hutchinson-Gilford Progeria Syndrome (HGPS) and a spectrum of diseases known as "laminopathies". This project addresses fundamental unanswered questions about Lamin A biology, including how it is processed within the cell and how abnormal processing can cause disease, as in HGPS. Our studies will provide insight into potential therapeutic options for premature aging disorders, and may also shed light on the mechanisms underlying the normal aging process.
描述(由申请人提供):该项目的重点是lamin A的生物发生,这是核包膜的关键结构成分。 Surprisingly, recent studies have revealed that mutations in the gene encoding Lamin A result in a wide range of diseases called the "laminopathies" (encompassing cardiomyopathy, muscular dystrophy, lipodystrophy, and progeroid disorders), leading to a resurgence of interest in the biology of Lamin A. The Lamin A precursor, prelamin A, undergoes a series of翻译后处理事件,包括:1)C-终末CAAX修饰(原质化,蛋白水解和羧基甲基化),然后是2)2)一个内蛋白溶解裂解事件,由锌金属蛋白酶ZMPSTE24介导,从而消除了Cax-Modified C- Termerinus fiervered C- Termerinus A.在此期间,这是在这种情况下进行的。 ZMPSTE24作为酵母A因子生物发生的关键酶。从这些发现中,该项目已演变为研究哺乳动物细胞中层蛋白A的生物发生。最严重的椎板病是Hutchinson-Gilford综合征(HGPS)的过早衰老疾病。 Strikingly, there appears to be a direct link between defective Zmpste24-mediated endoproteolytic processing of prelamin A and progeroid diseases based on the findings that: 1) HGPS results from a mutation in which the ZmpSte24 cleavage site within Lamin A is deleted, and 2) the progeroid disorders mandibuloacral dysplasia (MAD) and restrictive皮肤病(RD)映射到ZMPSTE24。因此,似乎存在于HGPS或ZMPSTE24 - / - 细胞中的lamin A的持续原型化形式导致加速衰老的病理。在此提案中,我们将定义层粘连蛋白A处理的关键细胞生物学方面,并解决缺乏加工在疾病机制中所发挥的作用。我们将使用分子,细胞生物学,遗传和生化方法来解决以下目的:目标1)确定层粘连蛋白A加工的细胞位置(核质和ER的胞质面);目标2)确定切割的c-末端尾巴的命运; AIM 3)确定预胺内的识别序列对于ZMPSTE24裂解很重要,并使用纯化的酶来定义ZMPSTE24如何切割预裂解前A;目标4)研究未能裂解前尾能导致细胞和疾病表型的分子机制。特别是我们将测试甲基化是否可能有助于HGP中层粘连蛋白A的毒性。令人着迷的发现,即前代疾病是由预胺A的不完整处理引起的,这强调了对整个加工途径的全面理解的重要性,我们在本提案中解决了这一问题。我们的研究将提供对孕激素疾病治疗选择的见解。最近发现,抑制ZMPSTE24介导的预胺A的加工可能有助于HIV治疗引起的副作用,并可能有可能促进正常衰老的机制,从而提高了这项研究的意义。 公共卫生相关性:核结构蛋白层固定蛋白A的突变导致过早衰老疾病Hutchinson-Gilford progeria综合征(HGP)和一系列被称为“椎板病”的疾病。该项目解决了有关层固定生物学的基本未解决的问题,包括在细胞内处理方式以及异常处理可能引起疾病,如HGP中。我们的研究将洞悉过早衰老疾病的潜在治疗选择,并可能阐明正常衰老过程的机制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Susan D. Michaelis其他文献

Susan D. Michaelis的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Susan D. Michaelis', 18)}}的其他基金

Role for prelamin A in premature and physiological aging
Prelamin A 在过早衰老和生理衰老中的作用
  • 批准号:
    10672409
  • 财政年份:
    2022
  • 资助金额:
    $ 32.51万
  • 项目类别:
The integral membrane protease ZMPSTE24, lamin A processing, and the premature aging disease progeria
整合膜蛋白酶ZMPSTE24、核纤层蛋白A加工与早衰症早衰症
  • 批准号:
    10654442
  • 财政年份:
    2018
  • 资助金额:
    $ 32.51万
  • 项目类别:
The integral membrane protease ZMPSTE24, lamin A processing, and the premature aging disease progeria
整合膜蛋白酶ZMPSTE24、核纤层蛋白A加工与早衰症早衰症
  • 批准号:
    10469090
  • 财政年份:
    2018
  • 资助金额:
    $ 32.51万
  • 项目类别:
Role of the integral membrane protease ZMPSTE24 in membrane protein biogenesis and virus-host cell fusion
整合膜蛋白酶 ZMPSTE24 在膜蛋白生物发生和病毒-宿主细胞融合中的作用
  • 批准号:
    10622926
  • 财政年份:
    2018
  • 资助金额:
    $ 32.51万
  • 项目类别:
The integral membrane protease ZMPSTE24, lamin A processing, and the premature aging disease progeria
整合膜蛋白酶ZMPSTE24、核纤层蛋白A加工与早衰症早衰症
  • 批准号:
    10439781
  • 财政年份:
    2018
  • 资助金额:
    $ 32.51万
  • 项目类别:
The integral membrane protease ZMPSTE24, lamin A processing, and the premature aging disease progeria
整合膜蛋白酶ZMPSTE24、核纤层蛋白A加工与早衰症早衰症
  • 批准号:
    10207666
  • 财政年份:
    2018
  • 资助金额:
    $ 32.51万
  • 项目类别:
FOLDING AND ACTIVITY OF ABC PROTEINS IN YEAST
酵母中 ABC 蛋白的折叠和活性
  • 批准号:
    6524274
  • 财政年份:
    1999
  • 资助金额:
    $ 32.51万
  • 项目类别:
FOLDING AND ACTIVITY OF ABC PROTEINS IN YEAST
酵母中 ABC 蛋白的折叠和活性
  • 批准号:
    6157648
  • 财政年份:
    1999
  • 资助金额:
    $ 32.51万
  • 项目类别:
FOLDING AND ACTIVITY OF ABC PROTEINS IN YEAST
酵母中 ABC 蛋白的折叠和活性
  • 批准号:
    6178512
  • 财政年份:
    1999
  • 资助金额:
    $ 32.51万
  • 项目类别:
FOLDING AND ACTIVITY OF ABC PROTEINS IN YEAST
酵母中 ABC 蛋白的折叠和活性
  • 批准号:
    6381892
  • 财政年份:
    1999
  • 资助金额:
    $ 32.51万
  • 项目类别:

相似国自然基金

阿魏酸基天然抗氧化抗炎纳米药物用于急性肾损伤诊疗一体化研究
  • 批准号:
    82302281
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
  • 批准号:
    82300697
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于hemin-MOFs的急性心肌梗塞标志物负背景光电化学-比色双模分析
  • 批准号:
    22304039
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
RNA甲基转移酶NSUN2介导SCD1 mRNA m5C修饰调控急性髓系白血病细胞铁死亡的机制研究
  • 批准号:
    82300173
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于IRF5/MYD88信号通路调控巨噬细胞M1极化探讨针刀刺营治疗急性扁桃体炎的机制研究
  • 批准号:
    82360957
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

A Sample-to-Answer Point-of-Care Diagnostic for Recently Transfused Sickle Cell Anemia Patients in Low Resource Settings
针对资源匮乏地区最近输血的镰状细胞性贫血患者的从样本到答案的护理点诊断
  • 批准号:
    10564553
  • 财政年份:
    2023
  • 资助金额:
    $ 32.51万
  • 项目类别:
B Cell Biology in the Context of Infectious Diseases, Autoimmunity and B Cell Cancers
传染病、自身免疫和 B 细胞癌症背景下的 B 细胞生物学
  • 批准号:
    10683443
  • 财政年份:
    2023
  • 资助金额:
    $ 32.51万
  • 项目类别:
Cellular rejuvenation during oogenesis
卵子发生过程中的细胞再生
  • 批准号:
    10864188
  • 财政年份:
    2023
  • 资助金额:
    $ 32.51万
  • 项目类别:
Delineating ARF negative regulation of PAF1C-dependent oncogenic programs
描绘 ARF 对 PAF1C 依赖性致癌程序的负调控
  • 批准号:
    10437541
  • 财政年份:
    2022
  • 资助金额:
    $ 32.51万
  • 项目类别:
Genetic requirements for executing SUMO stress signals and achieving stress tolerance
执行 SUMO 应激信号和实现应激耐受性的遗传要求
  • 批准号:
    10514836
  • 财政年份:
    2022
  • 资助金额:
    $ 32.51万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了